Ryan N. Henderson

Array ( [id] => 8464607 [patent_doc_number] => 20120269775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Adipose Stromal Stem Cells For Tissue And Vascular Modification' [patent_app_type] => utility [patent_app_number] => 13/279222 [patent_app_country] => US [patent_app_date] => 2011-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12272 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134350 [patent_doc_number] => 20130295064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'CARDIAC INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE IN REPAIR AND REGENERATION OF MYOCARDIUM' [patent_app_type] => utility [patent_app_number] => 13/879350 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17263 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9150873 [patent_doc_number] => 20130305396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'ENGINEERED HUMAN ENDOSIALIN-EXPRESSING RODENTS' [patent_app_type] => utility [patent_app_number] => 13/876232 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17446 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11792713 [patent_doc_number] => 09402377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Human SIRPAalpha transgenic animals and their methods of use' [patent_app_type] => utility [patent_app_number] => 13/847636 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 9 [patent_no_of_words] => 14726 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669564 [patent_doc_number] => 20110318833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'ADIPOSE-DERIVED STEM CELLS AND LATICCES' [patent_app_type] => utility [patent_app_number] => 13/226338 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9756 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13226338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041415 [patent_doc_number] => 20120070444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/225033 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070444.pdf [firstpage_image] =>[orig_patent_app_number] => 13225033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656409 [patent_doc_number] => 20110305678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'USE OF MESENCHYMAL STEM CELLS FOR TREATING GENETIC DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/216880 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6531 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305678.pdf [firstpage_image] =>[orig_patent_app_number] => 13216880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7714738 [patent_doc_number] => 20120005766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Methods of identifying agents that modulate phenotypes related to disruptions, of a gene encoding PRO235 polypeptide' [patent_app_type] => utility [patent_app_number] => 13/205917 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 202608 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20120005766.pdf [firstpage_image] =>[orig_patent_app_number] => 13205917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580326 [patent_doc_number] => 20110294209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'METHODS FOR PRODUCING NONADHERENT AVIAN CELL LINES' [patent_app_type] => utility [patent_app_number] => 13/206056 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11266 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294209.pdf [firstpage_image] =>[orig_patent_app_number] => 13206056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7760373 [patent_doc_number] => 20120030778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'GENOMIC EDITING OF GENES INVOLVED WITH PARKINSONS DISEASE' [patent_app_type] => utility [patent_app_number] => 13/191901 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15906 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20120030778.pdf [firstpage_image] =>[orig_patent_app_number] => 13191901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11779137 [patent_doc_number] => 09388233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Rat having a disrupted immunoglobulin gene' [patent_app_type] => utility [patent_app_number] => 13/192407 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14797 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13192407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580336 [patent_doc_number] => 20110294219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'USE OF THE FOAMY VIRUS BET PROTEIN FOR INACTIVATING APOBEC' [patent_app_type] => utility [patent_app_number] => 13/180881 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5437 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294219.pdf [firstpage_image] =>[orig_patent_app_number] => 13180881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675286 [patent_doc_number] => 08383399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Nucleic acid construct having an ovalbumin promotor' [patent_app_type] => utility [patent_app_number] => 13/179281 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 12632 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13179281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8455319 [patent_doc_number] => 20120266265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Transgenic avians and protein production' [patent_app_type] => utility [patent_app_number] => 13/168645 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19779 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8042269 [patent_doc_number] => 20120070861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Human Lambda Light Chain Mice' [patent_app_type] => utility [patent_app_number] => 13/166171 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26404 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070861.pdf [firstpage_image] =>[orig_patent_app_number] => 13166171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491167 [patent_doc_number] => 20110252485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Novel gene disruptions, compositions and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 13/159202 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 75732 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20110252485.pdf [firstpage_image] =>[orig_patent_app_number] => 13159202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7513006 [patent_doc_number] => 20110258716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'MODULATING IMMUNE SYSTEM DEVELOPMENT AND FUNCTION THROUGH MICRORNA MIR-146' [patent_app_type] => utility [patent_app_number] => 13/151053 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11984 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20110258716.pdf [firstpage_image] =>[orig_patent_app_number] => 13151053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857300 [patent_doc_number] => 08883496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Humanized FcgR mice' [patent_app_type] => utility [patent_app_number] => 13/113677 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17713 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13113677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850770 [patent_doc_number] => 08877448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Method of making recombinant influenza virus' [patent_app_type] => utility [patent_app_number] => 13/106080 [patent_app_country] => US [patent_app_date] => 2011-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13855 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13106080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8059869 [patent_doc_number] => 20110247089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Organisms homozygous for targeted modification' [patent_app_type] => utility [patent_app_number] => 13/066636 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14995 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20110247089.pdf [firstpage_image] =>[orig_patent_app_number] => 13066636 [rel_patent_id] =>[rel_patent_doc_number] =>)